All Articles tagged lung cancer

• Oncology
  September 17, 2024 EDT
  Economic Evaluation of a Novel Lung Cancer Diagnostic in a Population of Patients with a Positive Low-Dose Computed Tomography Result
  Michael J. MorrisSheila A. HabibMaggie L. Do ValleJohn E. Schneider

  We evaluate potential cost savings for US payers of CyPath® Lung, a novel diagnostic tool utilizing flow cytometry and machine learning, for the early detection of lung cancer.

  Abstract
• Oncology
  February 17, 2022 EDT
  Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece
  George GourzoulidisOresteia ZisimopoulouNadia BoubouchairopoulouChristina MichailidiChrissy LowryCharalampos TzanetakosGeorgia Kourlaba

  The present study assessed the cost-effectiveness of lorlatinib versus pemetrexed with platinum combination of carboplatin or cisplatin (P-ChT) in Greece.

  Abstract
• Oncology
  September 14, 2020 EDT
  Diagnostic Accuracy of Next Generation Sequencing Panel using Circulating Tumor DNA in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
  Mariana M. SebastiãoRodrigo S. HoJoão Paulo V. de CarvalhoMicha Nussbaum

  This study carries out a systematic review and a meta-analysis in order to determine the accuracy of NGS of ctDNA to detect six oncogenic driver alterations.

  Abstract
• Methodology and Healthcare Policy
  May 08, 2019 EDT
  No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients
  Bruce S. PyensonCarol M. BazellMichael J. BellanichMelissa A. CaplenJavier J. Zulueta

  We examine the pattern and cost of pulmonary nodule (IPN) workup in real-world practice using insurer administrative claims data for commercially-insured individuals.

  Abstract